1887
Volume 2013, Issue 1
  • ISSN: 2220-2749
  • E-ISSN:

Abstract

Preeclampsia is a pregnancy specific condition characterized by hypertension and proteinuria. It complicates about 10% of all pregnancies. It is a major cause of maternal and fetal morbidity and mortality. Interestingly, preeclampsia may have an impact on the health of the mother or infant, beyond the pregnancy. It is believed that several ligands and receptors of different families of growth factors have been involved in the development of preeclampsia. We performed a systematic search of PubMed including combination of terms such as preeclampsia, growth factors, treatment, vascular endothelial growth factor A, activin A, inhibin A, placental growth factor, transforming growth factor β-1, Nodal, placenta, trophoblast cells, biomarkers and detection. In this review we have summarized current knowledge on the role of growth factors in early detection and treatment of preeclampsia. Although these growth factors have significant roles in normal and complicated pregnancies, the current value of these growth factors as biomarkers, for the precise prediction of preeclampsia, has its limitation. Therefore, future studies need to be done to support some of the very promising and interesting data to develop affordable and widely available tests for early detection and treatment of preeclampsia.

Loading

Article metrics loading...

/content/journals/10.5339/avi.2013.4
2013-09-01
2019-08-20
Loading full text...

Full text loading...

/deliver/fulltext/avi/2013/1/avi.2013.4.html?itemId=/content/journals/10.5339/avi.2013.4&mimeType=html&fmt=ahah

References

  1. [1]. Scazzocchio   E., , Figueras   F. . Contemporary prediction of preeclampsia. . Curr Opin Obstet Gynecol . 2011; ;23: : 65– 71
    [Google Scholar]
  2. [2]. Tang   LC., , Kwok   AC., , Wong   AY., , Lee   YY., , Sun   KO., , So   AP. . Critical care in obstetrical patients: an eight-year review. . Chin Med J (Engl) . 1997; ;110: 12 : 936– 941
    [Google Scholar]
  3. [3]. Hawfield   A., , Freedman   BI. . Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. . Ther Adv Cardiovasc Dis . 2009; ;3: : 65– 73
    [Google Scholar]
  4. [4]. Tomsin   K., , Mesens   T., , Molenberghs   G., , Peeters   L., , Gyselaers   W. . Characteristics of heart, arteries, and veins in low and high cardiac output preeclampsia. . Eur J Obstet Gynecol Reprod Biol . 2013; ; , pii: S0301-2115(13)00146-2. doi: 10.1016/j.ejogrb.2013.03.016. [Epub ahead of print]
    [Google Scholar]
  5. [5]. Garovic   VD., , August   P. . Preeclampsia and the future risk of hypertension: the pregnant evidence. . Curr Hypertens Rep . 2013; ;15: : 114– 121
    [Google Scholar]
  6. [6]. Berks   D., , Hoedjes   M., , Raat   H., , Duvekot   JJ., , Steegers   EA., , Habbema   JD. . Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study. . BJOG . 2013; ;120: 8 : 924– 931 , doi: 10.1111/1471-0528.12191. Epub Mar 26, 2013
    [Google Scholar]
  7. [7]. Ghazal-Aswad   S., , Badrinath   P., , Sidky   I., , Safi   TH., , Gargash   H., , Abdul-Razak   Y., , Mirghani   H. . Severe acute maternal morbidity in a high-income developing multiethnic country. . Matern Child Health J . 2013; ;17: 3 : 399– 404
    [Google Scholar]
  8. [8]. Jido   TA., , Yakasai   IA. . Preeclampsia: a review of the evidence. . Ann Afr Med . 2013; ;12: : 75– 85
    [Google Scholar]
  9. [9]. Mattar   F., , Sibai   BM. . Eclampsia. VIII. Risk factors for maternal morbidity. . Am J Obstet Gynecol . 2000; ;182: : 307– 312
    [Google Scholar]
  10. [10]. Masuyama   H., , Nobumoto   E., , Segawa   T., , Hiramatsu   Y. . Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors. . Acta Med Okayama . 2012; ;66: : 171– 175
    [Google Scholar]
  11. [11]. Raymond   D., , Peterson   E. . A critical review of early-onset and late-onset preeclampsia. . Obstet Gynecol Surv . 2011; ;66: : 497– 506
    [Google Scholar]
  12. [12]. Hasko   M., , Biringer   K., , Biskupska   BK., , Danko   J. . Selected markers in early prediction of preeclampsia. . Ceska Gynekol . 2011; ;76: : 135– 139
    [Google Scholar]
  13. [13]. Maynard   S., , Epstein   FH., , Karumanchi   SA. . Preeclampsia and angiogenic imbalance. . Annu Rev Med . 2008; ;59: : 61– 78
    [Google Scholar]
  14. [14]. Than   NG., , Romero   R., , Hillermann   R., , Cozzi   V., , Nie   G., , Huppertz   B. . Prediction of preeclampsia – a workshop report. . Placenta . 2008; ;29: : S83– S85
    [Google Scholar]
  15. [15]. Thangaratinam   S., , Langenveld   J., , Mol   BW., , Khan   KS. . Prediction and primary prevention of pre-eclampsia. . Best Pract Res Clin Obstet Gynaecol . 2011; ;25: : 419– 433
    [Google Scholar]
  16. [16]. Beaufils   M. . Pregnancy hypertension. . Nephrol Ther . 2010; ;6: : 200– 214
    [Google Scholar]
  17. [17]. Boulanger   H., , Flamant   M. . New insights in the pathophysiology of preeclampsia and potential therapeutic implications. . Nephrol Ther . 2007; ;3: : 437– 448
    [Google Scholar]
  18. [18]. Grill   S., , Rusterholz   C., , Zanetti-Dällenbach   R., , Tercanli   S., , Holzgreve   W., , Hahn   S., , Lapaire   O. . Potential markers of preeclampsia–a review. . Reprod Biol Endocrinol . 2009; ;7: : 70 . doi: 10.1186/1477-7827-7-70
    [Google Scholar]
  19. [19]. Meads   CA., , Cnossen   JS., , Meher   S., , Juarez-Garcia   A., , ter Riet   G., , Duley   L., , Roberts   TE., , Mol   BW., , van der Post   JA., , Leeflang   MM., , Barton   PM., , Hyde   CJ., , Gupta   JK., , Khan   KS. . Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. . Health Technol Assess . 2008; ;12: : 1– 270
    [Google Scholar]
  20. [20]. Goldenberg   RL., , McClure   EM., , Macguire   ER., , Kamath   BD., , Jobe   AH. . Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. . Int J Gynaecol Obstet . 2011; ;113: 2 : 91– 95
    [Google Scholar]
  21. [21]. Kuc   S., , Wortelboer   EJ., , van Rijn   BB., , Franx   A., , Visser   GH., , Schielen   PC. . Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. . Obstet Gynecol Surv . 2011; ;66: 4 : 225– 239
    [Google Scholar]
  22. [22]. Hertig   A., , Liere   P. . New markers in preeclampsia. . Clin Chim Acta . 2010; ;411: : 1591– 1595
    [Google Scholar]
  23. [23]. Papageorghiou   AT., , Campbell   S. . First trimester screening for preeclampsia. . Curr Opin Obstet Gynecol . 2006; ;18: : 594– 600
    [Google Scholar]
  24. [24]. Smets   EM., , Visser   A., , Go   ATJI., , van Vugt   JMG., , Oudejans   CBM. . Novel biomarkers in preeclampsia. . Clin Chim Acta . 2006; ;364: : 22– 32
    [Google Scholar]
  25. [25]. Maynard   SE., , Karumanchi   SA. . Angiogenic factors and preeclampsia. . Semin Nephrol . 2011; ;31: : 33– 46
    [Google Scholar]
  26. [26]. Yu   L., , Li   D., , Liao   QP., , Yang   HX., , Cao   B., , Fu   G., , Ye   G., , Bai   Y., , Wang   H., , Cui   N., , Liu   M., , Li   YX., , Li   J., , Peng   C., , Wang   YL. . High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling. . J Clin Endocrinol Metab . 2012; ;97: 8 : E1370– E1379
    [Google Scholar]
  27. [27]. Pijnenborg   R., , Robertson   WB., , Brosens   I., , Dixon   G. . Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. . Placenta . 1981; ;2: : 71– 91
    [Google Scholar]
  28. [28]. Pijnenborg   R., , Bland   JM., , Robertson   WB., , Dixon   G., , Brosens   I. . The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. . Placenta . 1981; ;2: 4 : 303– 316
    [Google Scholar]
  29. [29]. Pijnenborg   R., , Anthony   J., , Davey   DA., , Rees   A., , Tiltman   A., , Vercruysse   L., , van Assche   A. . Placental bed spiral arteries in the hypertensive disorders of pregnancy. . Br J Obstet Gynaecol . 1991; ;98: 7 : 648– 655
    [Google Scholar]
  30. [30]. Pietro   L., , Daher   S., , Rudge   MV., , Calderon   IM., , Damasceno   DC., , Sinzato   YK., , Bandeira   C., , Bevilacqua   E. . Vascular endothelial growth factor and VEGF-receptor expression in placenta of hyperglycaemic pregnant women. . Placenta . 2010; ;31: : 770– 780
    [Google Scholar]
  31. [31]. Levine   RJ., , Thadhani   R., , Qian   C., , Lam   C., , Lim   KH., , Yu   KF., , Blink   AL., , Sachs   BP., , Epstein   FH., , Sibai   BM., , Sukhatme   VP., , Karumanchi   SA. . Urinary placental growth factor and risk of preeclampsia. . JAMA . 2005; ;293: : 77– 85
    [Google Scholar]
  32. [32]. Akolekar   R., , Zaragoza   E., , Poon   LC., , Pepes   S., , Nicolaides   KH. . Maternal serum placental growth factor at 110 to 136 weeks of gestation in the prediction of pre-eclampsia. . Ultrasound Obstet Gynecol . 2008; ;32: : 732– 739
    [Google Scholar]
  33. [33]. Tossidou   I., , Schiffer   M. . TGF-beta/BMP pathways and the podocyte. . Semin Nephrol . 2012; ;32: : 368– 376
    [Google Scholar]
  34. [34]. Chen   Q., , Chen   L., , Liu   B., , Vialli   C., , Stone   P., , Ching   LM., , Chamley   L. . The role of autocrine TGFbeta1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre-eclampsia. . J Pathol . 2010; ;221: 1 : 87– 95
    [Google Scholar]
  35. [35]. Walton   KL., , Makanji   Y., , Harrison   CA. . New insights into the mechanisms of activin action and inhibition. . Mol Cell Endocrinol . 2012; ;359: : 2– 12
    [Google Scholar]
  36. [36]. Robertson   DM. . Inhibins and activins in blood: predictors of female reproductive health?.   Mol Cell Endocrinol . 2012; ;359: : 78– 84
    [Google Scholar]
  37. [37]. Morris   JM., , Gopaul   NK., , Endresen   MJ., , Knight   M., , Linton   EA., , Dhir   S., , Anggård   EE., , Redman   CW. . Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. . Br J Obstet Gynaecol . 1998; ;105: 11 : 1195– 1199
    [Google Scholar]
  38. [38]. Lim   JH., , Kim   SY., , Park   SY., , Lee   MH., , Yang   JH., , Kim   MY., , Chung   JH., , Lee   SW., , Ryu   HM. . Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia. . Prenat Diagn . 2009; ;29: : 471– 476
    [Google Scholar]
  39. [39]. ten Dijke   P., , Goumans   MJ., , Pardali   E. . Endoglin in angiogenesis and vascular diseases. . Angiogenesis . 2008; ;11: : 79– 89
    [Google Scholar]
  40. [40]. Munir   S., , Xu   G., , Wu   Y., , Yang   B., , Lala   PK., , Peng   C. . Nodal and ALK7 inhibit proliferation and induce apoptosis in human trophoblast cells. . J Biol Chem . 2004; ;279: : 31277– 31286
    [Google Scholar]
  41. [41]. Fu   G., , Ye   G., , Nadeem   L., , Ji   L., , Manchanda   T., , Wang   Y., , Zhao   Y., , Qiao   J., , Wang   YL., , Lye   S., , Yang   BB., , Peng   C. . MicroRNA-376c impairs transforming growth factor-beta and nodal signaling to promote trophoblast cell proliferation and invasion. . Hypertension . 2013; ;61: : 864– 872
    [Google Scholar]
  42. [42]. Florio   P., , Gabbanini   M., , Borges   LE., , Bonaccorsi   L., , Pinzauti   S., , Reis   FM., , Boy Torres   P., , Rago   G., , Litta   P., , Petraglia   F. . Activins and related proteins in the establishment of pregnancy. . Reprod Sci . 2010; ;17: 4 : 320– 330
    [Google Scholar]
  43. [43]. McNeilly   AS. . Diagnostic applications for inhibin and activins. . Mol Cell Endocrinol . 2012; ;359: : 121– 125
    [Google Scholar]
  44. [44]. Peng   C., , Mukai   ST. . Activins and their receptors in female reproduction. . Biochem Cell Biol . 2000; ;78: : 261– 279
    [Google Scholar]
  45. [45]. Feizollahzadeh   S., , Taheripanah   R., , Khani   M., , Farokhia   B., , Amani   D. . Promoter region polymorphisms in the transforming growth factor beta-1 (TGFbeta1) gene and serum TGFbeta1 concentration in preeclamptic and control Iranian women. . J Reprod Immunol . 2012; ;94: : 216– 221
    [Google Scholar]
  46. [46]. Yinon   Y., , Nevo   O., , Xu   J., , Many   A., , Rolfo   A., , Todros   T., , Post   M., , Caniggia   I. . Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3. . Am J Pathol . 2008; ;172: 1 : 77– 85
    [Google Scholar]
  47. [47]. Ferrara   N. . Vascular endothelial growth factor and the regulation of angiogenesis. . Recent Prog Horm Res . 2000; ;55: : 15– 35 , ; discussion 35–6
    [Google Scholar]
  48. [48]. de Vries   C., , Escobedo   JA., , Ueno   H., , Houck   K., , Ferrara   N., , Williams   LT. . The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. . Science . 1992; ;255: : 989– 991
    [Google Scholar]
  49. [49]. Purwosunu   Y., , Sekizawa   A., , Yoshimura   S., , Farina   A., , Wibowo   N., , Nakamura   M., , Shimizu   H., , Okai   T. . Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. . Reprod Sci . 2009; ;16: : 857– 864
    [Google Scholar]
  50. [50]. Gerber   HP., , Condorelli   F., , Park   J., , Ferrara   N. . Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. . J Biol Chem . 1997; ;272: : 23659– 23667
    [Google Scholar]
  51. [51]. Andraweera   PH., , Dekker   GA., , Roberts   CT. . The vascular endothelial growth factor family in adverse pregnancy outcomes. . Hum Reprod Update . 2012; ;18: : 436– 457
    [Google Scholar]
  52. [52]. Many   A., , Hubel   CA., , Fisher   SJ., , Roberts   JM., , Zhou   Y. . Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. . Am J Pathol . 2000; ;156: : 321– 331
    [Google Scholar]
  53. [53]. Zhou   Y., , Genbacev   O., , Damsky   CH., , Fisher   SJ. . Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia. . J Reprod Immunol . 1998; ;39: : 197– 213
    [Google Scholar]
  54. [54]. Zhou   Y., , Damsky   CH., , Fisher   SJ. . Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?.   J Clin Invest . 1997; ;99: : 2152– 2164
    [Google Scholar]
  55. [55]. Verdonk   K., , Visser   W., , Steegers   EA., , Kappers   M., , Danser   AH., , van den Meiracker   AH. . New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors. . Ned Tijdschr Geneeskd . 2011; ;155: : A2946
    [Google Scholar]
  56. [56]. Chaiworapongsa   T., , Romero   R., , Espinoza   J., , Bujold   E., , Mee Kim   Y., , Gonçalves   LF., , Gomez   R., , Edwin   S. . Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. . Am J Obstet Gynecol . 2004; ;190: 6 : 1541– 1547 , ; discussion 1547–50
    [Google Scholar]
  57. [57]. Li   Z., , Zhang   Y., , Ying Ma   J., , Kapoun   AM., , Shao   Q., , Kerr   I., , Lam   A., , O'Young   G., , Sannajust   F., , Stathis   P., , Schreiner   G., , Karumanchi   SA., , Protter   AA., , Pollitt   NS. . Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. . Hypertension . 2007; ;50: : 686– 692
    [Google Scholar]
  58. [58]. De Falco   S., , Gigante   B., , Persico   MG. . Structure and function of placental growth factor. . Trends Cardiovasc Med . 2002; ;12: : 241– 246
    [Google Scholar]
  59. [59]. Levine   RJ., , Maynard   SE., , Qian   C., , Lim   KH., , England   LJ., , Yu   KF., , Schisterman   EF., , Thadhani   R., , Sachs   BP., , Epstein   FH., , Sibai   BM., , Sukhatme   VP., , Karumanchi   SA. . Circulating angiogenic factors and the risk of preeclampsia. . N Engl J Med . 2004; ;350: : 672– 683
    [Google Scholar]
  60. [60]. Poon   LC., , Zaragoza   E., , Akolekar   R., , Anagnostopoulos   E., , Nicolaides   KH. . Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(0) to 13(6) weeks of gestation. . Prenat Diagn . 2008; ;28: : 1110– 1115
    [Google Scholar]
  61. [61]. Sunderji   S., , Gaziano   E., , Wothe   D., , Rogers   LC., , Sibai   B., , Karumanchi   SA., , Hodges-Savola   C. . Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. . Am J Obstet Gynecol . 2010; ;202: : 40e1– 40e7
    [Google Scholar]
  62. [62]. Verlohren   S., , Galindo   A., , Schlembach   D., , Zeisler   H., , Herraiz   I., , Moertl   MG., , Pape   J., , Dudenhausen   JW., , Denk   B., , Stepan   H. . An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. . Am J Obstet Gynecol . 2010; ;202: : 161e1– 161e11
    [Google Scholar]
  63. [63]. Xu   G., , Zhong   Y., , Munir   S., , Yang   BB., , Tsang   BK., , Peng   C. . Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. . J Clin Endocrinol Metab . 2004; ;89: : 5523– 5534
    [Google Scholar]
  64. [64]. Roten   LT., , Johnson   MP., , Forsmo   S., , Fitzpatrick   E., , Dyer   TD., , Brennecke   SP., , Blangero   J., , Moses   EK., , Austgulen   R. . Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). . Eur J Hum Genet . 2009; ;17: : 250– 257
    [Google Scholar]
  65. [65]. Fitzpatrick   E., , Johnson   MP., , Dyer   TD., , Forrest   S., , Elliott   K., , Blangero   J., , Brennecke   SP., , Moses   EK. . Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia. . Mol Hum Reprod . 2009; ;15: : 195– 204
    [Google Scholar]
  66. [66]. Ma   GT., , Soloveva   V., , Tzeng   SJ., , Lowe   LA., , Pfendler   KC., , Iannaccone   PM., , Kuehn   MR., , Linzer   DI. . Nodal regulates trophoblast differentiation and placental development. . Dev Biol . 2001; ;236: : 124– 135
    [Google Scholar]
  67. [67]. Guzman-Ayala   M., , Ben-Haim   N., , Beck   S., , Constam   DB. . Nodal protein processing and fibroblast growth factor 4 synergize to maintain a trophoblast stem cell microenvironment. . Proc Natl Acad Sci U S A . 2004; ;101: : 15656– 15660
    [Google Scholar]
  68. [68]. Nadeem   L., , Munir   S., , Fu   G., , Dunk   C., , Baczyk   D., , Caniggia   I., , Lye   S., , Peng   C. . Nodal signals through activin receptor-like kinase 7 to inhibit trophoblast migration and invasion: implication in the pathogenesis of preeclampsia. . Am J Pathol . 2011; ;178: : 1177– 1189
    [Google Scholar]
  69. [69]. Lim   JH., , Kim   SY., , Park   SY., , Yang   JH., , Kim   MY., , Ryu   HM. . Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. . Obstet Gynecol . 2008; ;111: : 1403– 1409
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/avi.2013.4
Loading
/content/journals/10.5339/avi.2013.4
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error